BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 7518993)

  • 1. Periosteal osteosarcoma and parosteal chondrosarcoma evaluated by double immunohistochemical staining. Report of 2 cases.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H
    Acta Orthop Scand; 1994 Jun; 65(3):355-8. PubMed ID: 7518993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
    Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
    Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identity of proliferating cells in bone tumors with cartilaginous components: evaluation by double-immunohistochemical staining using proliferating cell nuclear antigen and S-100 protein.
    Chano T; Ishizawa M; Matsumoto K; Morimoto S; Hukuda S; Okabe H
    Eur J Histochem; 1995; 39(1):21-30. PubMed ID: 7612954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different and identical features of chondroblastic osteosarcoma and chondrosarcoma: highlights on radiography and magnetic resonance imaging.
    Yen CH; Chang CY; Teng MM; Wu HT; Chen PC; Chiou HJ; Chiu NC
    J Chin Med Assoc; 2009 Feb; 72(2):76-82. PubMed ID: 19251535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma.
    Gomez-Brouchet A; Mourcin F; Gourraud PA; Bouvier C; De Pinieux G; Le Guelec S; Brousset P; Delisle MB; Schiff C
    Hum Pathol; 2010 Sep; 41(9):1220-30. PubMed ID: 20399482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDM2 and CDK4 expression in periosteal osteosarcoma.
    Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
    Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periosteal chondrosarcoma: a case report and review of the literature.
    Putti TC; Kahn LB; Aprin H
    Arch Pathol Lab Med; 1997 Jan; 121(1):70-4. PubMed ID: 9111097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ultrastructure of conventional, parosteal, and periosteal osteosarcomas.
    Martínez-Tello FJ; Navas-Palacios JJ
    Cancer; 1982 Sep; 50(5):949-61. PubMed ID: 6953992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DACH1 Expresison in Osteosarcoma and Its Relationship with Proliferation and Angiogenesis.
    Ren P; Gong MZ; Wang ZY; Zhang P; Chen P; Ma WL; Zhou CJ
    Indian J Surg; 2015 Jun; 77(3):200-5. PubMed ID: 26246702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcomas and chondrosarcomas of the jaws: immunohistochemical correlations.
    Regezi JA; Zarbo RJ; McClatchey KD; Courtney RM; Crissman JD
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):302-7. PubMed ID: 2443891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periosteal chondrosarcoma and periosteal osteosarcoma. Two distinct entities.
    Bertoni F; Boriani S; Laus M; Campanacci M
    J Bone Joint Surg Br; 1982; 64(3):370-6. PubMed ID: 7096408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma.
    Salas S; de Pinieux G; Gomez-Brouchet A; Larrousserie F; Leroy X; Aubert S; Decouvelaere AV; Giorgi R; Fernandez C; Bouvier C
    Virchows Arch; 2009 Jan; 454(1):81-7. PubMed ID: 19050913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis.
    Chen P; Wang SJ; Wang HB; Ren P; Wang XQ; Liu WG; Gu WL; Li DQ; Zhang TG; Zhou CJ
    J Mol Histol; 2012 Feb; 43(1):63-70. PubMed ID: 22042095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondroblastic osteosarcoma of the cuboid: a literature review and report of a rare case.
    Fox C; Husain ZS; Shah MB; Lucas DR; Saleh HA
    J Foot Ankle Surg; 2009; 48(3):388-93. PubMed ID: 19423044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
    Devaney K; Vinh TN; Sweet DE
    Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periosteal osteosarcoma of the jaws: report of 2 cases.
    Piattelli A; Favia GF
    J Periodontol; 2000 Feb; 71(2):325-9. PubMed ID: 10711625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytogenesis and histogenesis of malignant and semimalignant bone tumors].
    Roessner A; Grundmann E
    Veroff Pathol; 1984; 122():1-195. PubMed ID: 6091360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitions of osteosarcoma, chondrosarcoma, and fibrosarcoma of bone.
    Sanerkin NG
    Cancer; 1980 Jul; 46(1):178-85. PubMed ID: 6930319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
    Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
    Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.